inflammation and disease
TRANSCRIPT
-
8/13/2019 Inflammation and Disease
1/43
INFLAMMATION &
DISEASEJessica Nagelkirk, NDSeptember 27, 2013
Marquette General Hospital
Nutrition and Medicine Conference
-
8/13/2019 Inflammation and Disease
2/43
Disclosures
-
8/13/2019 Inflammation and Disease
3/43
Wait, youre an ND not an MD?
Naturopathic physicians are primary care providers who
have graduated from an accredited 4-year medical school
after obtaining a bachelor degree that includes pre-
medicine studies. Complete nearly identical training in the basic sciences,
physical, laboratory, and imaging diagnostics,
pharmacology, and minor surgery procedures as
conventional medical school. Pass a national board examination comparable to the
USMLE step 1, 2, and 3 board examination.
Complete a residency program in family medicine.
-
8/13/2019 Inflammation and Disease
4/43
In addition to conventional training
Naturopathic physicians are experts in the use of
Nutritional IV Therapy
Clinical Nutrition
Botanical Medicine
Lifestyle Counseling
Environmental Medicine
Physical Medicine
Hydrotherapy
Homeopathy
-
8/13/2019 Inflammation and Disease
5/43
-
8/13/2019 Inflammation and Disease
6/43
Prasad S, et al. Age-associated chronic disease required age-old medicine: chronic ifnlammation. Prev Med. 2012 May; 54
-
8/13/2019 Inflammation and Disease
7/43
Inflammation and Disease
Inflammation occurs by both immune and non-immune
mediated mechanisms.
Both pathways lead to the production of reactive oxygenspecies (ROS), that alter cell metabolism, genes, and
epigenetics.
This sustained inflammatory/oxidative environment leadsto a vicious cycle eventually moving from physiologic
dysfunction to true physical pathology.
-
8/13/2019 Inflammation and Disease
8/43
Immune Mediated Mechanism
-
8/13/2019 Inflammation and Disease
9/43
Phospholipid/ Non-Immune Mechanisms
Linoleic Acid Arachidonic Acid Alpha-Linoleinic Acid
From plant based omega-6 fatty
acids like nuts, seeds, grains,
etc
From animal based omega-6
fatty acids
From fish and plant based
omega-3 fatty acids like flax
GLAEPAFound in borage, black currant,
evening primrose, human milk
Leukotrienes PGE2
COX I & II
5-lipoxygenase
DHA
PGE3
PGE1
Delta-5 Desaturase
Delta-6 Desaturase
Delta-6 Desaturase
Note: Some people are deficient in delta-6 desaturase, an
enzyme promoted by vitamin B3, B6, Mn, C, E and inhibited
by alcohol and stress.
DGLA
-
8/13/2019 Inflammation and Disease
10/43
Inflammation and Alterations
Gastroenterology 2012; 143:550-563 (DOI:10.1053/j.gastro.2012.07.009 )
-
8/13/2019 Inflammation and Disease
11/43
ROS-Linked Pathology
Diseases
Acute respiratory distress syndrome
Aging
Alzheimer
Atherosclerosis
Cardiovascular disease
Diabetes
Inflammation
Inflammatory joint disease
Neurological disease
Obesity Parkinson
Pulmonary fibrosis
Rheumatoid arthritis
Vascular disease
Cancer
Bladder
Brain
Breast
Cervical (secondary to HPV) Gastric
Liver
Lung
Melanoma
Multiple myeloma
Leukemia
Lymphoma Oral
Ovarian
Pancreatic
Prostate
sarcoma
Simone R, et al. Oxidative Stress, inflammation, & Cancer. Free Radical Biology and Medicine 2010
-
8/13/2019 Inflammation and Disease
12/43
Daily Aspirin
Aspirin is the acetylated form of salicylic acid.
It inhibits prostaglandin synthesis decreasing
inflammation but also causes GI bleeding.
Data concerning colorectal cancer has become verycompelling with regard to aspirins capacity to prevent
primary disease.
Recent data from multiple trials suggest that long-term
daily use of aspirin lowers risk for colorectal cancer.
Chronic inflammation has been linked to heart disease,
neurological disorders and cancer.
-
8/13/2019 Inflammation and Disease
13/43
Aspirin
Aspirin inhibits
cyclooxygenase
(COX)-1.
It also acetylatesCOX-2 turning
arachidonic acid
into the
intermediate 15-R-HETE which is
transformed into the
anti-inflammatory
ALT by neutrophils.
http://archives.focus.hms.harvard.edu/2004/Oct15_2004/anesthesia.html
-
8/13/2019 Inflammation and Disease
14/43
Aspirin and White Willow Bark (Salix alba)
Salix alba is considered to be the natural form and original
source of the modern aspirin.
Contains phenolic glycosides salicin and salicylic acid
It is the acetylation process of aspirin that allows it to act
on the COX-2 pathway decreasing inflammation.
White Willow Bark and other salicylate-containing herbs
are anti-inflammatory without danger to the stomach, but
do not utilize the same COX-2 pathway mechanism,
instead it down regulates COX expression.
-
8/13/2019 Inflammation and Disease
15/43
Anti-inflammatory Plant Constituents
Cyclooxygenase Inhibitors Flavonoids
Phenolic Phenylpropane derivatives
Naphthoquinones
Akyl amides Tannins
5-Lipoxygenase Inhibitors Phenolic structures
Arachidonic acid analogs
Long-chain unsaturated fatty acids
PAF Inhibitors Ginkgolides
Lignans and neolignans
-
8/13/2019 Inflammation and Disease
16/43
Plants Containing Steroid Precursors
Examples:
Glycyrrhiza gabrra
(Licorice)
Dioscorea villosa (Wild
Yam)
Most useful for auto-immune inflammation
-
8/13/2019 Inflammation and Disease
17/43
Essential Oil-Rich Plants
Examples: Matricaria recutita
(Chamomile)
Calendula officinalis
(Calendula) Hypericum perforatum (St.
Johns Wort)
Effective for digestivesystem inflammationwith taken PO. Effectivefor skin inflammationwhen used topically.
-
8/13/2019 Inflammation and Disease
18/43
Histamine Blocking
Examples:
Tanacetum parthenium
(Feverfew)
Scutellariabailcalensis(Chinese
Skullcap)
Ginkgo Biloba
-
8/13/2019 Inflammation and Disease
19/43
Inflammatory Enzyme Modulating
PhosphodiesteraseInhibitors Camellia sinensis (tansy)
Berberis (Oregon Grape)
Lipoxygenase Inhibitors Quercitin containing herbs
like Nettles
Cyclooxygenase
Inhibitors Salicylate containing herbs
like Betula (birch), Populus(Poplar), or Gaultheria(Wintergreen)
-
8/13/2019 Inflammation and Disease
20/43
Other Types
Many herbs seem to act in anti-inflammatory fashion but
have no known chemical anti-inflammatory component.
Coleus orskholii, Bupleurum, Tanacetum parthenium, Zingiber officinalis, Glycyrrhizaglabra, Scutellaria bicalensis, Panax ginseng, Crataegus oxyacantha, Zizphus, Asarum,
nidium, Phellodendron, Copis aponica, Allium cepa, Picrorrhiza kurroa, Tylophora
asthmatica, Capsella bursa, Ginkgo biloba, Camellia sinensis, Berberis, Schisandra,
Magnolia, Curcuma longa, Ananas comosus, Calendula officinalis, Matricaria spp,
Ficus elastica, Hypericum perforatum, Arnica montana, Vaccinium myrtillis, Silybum
marianum, Betula, Salix, Populis, Filipendula, Gaultheria, Spirea, Cimicifuga, Linumussitatissimum, Borago, Ribes, Onethera, Smilax, Yucca, Centella, Hemidesmmus,
Ganoderma, Coleus, Eleuthrococcus, Aloe vera, Lentinus, Chlorella, Cinnamomum,
Artemesia, Lavendula, Apium graveolens, Carica papaya, Eugenia, Commiphora
mukul, Angelica sinensis
-
8/13/2019 Inflammation and Disease
21/43
Turmeric (Curcuma longa)
-
8/13/2019 Inflammation and Disease
22/43
Turmeric
Effects
Anti-inflammatory
Antiplatelet aggregation
Antioxidant
Antimicrobial
Inhibits carcinogenesis
Carminative
Key Constituents
Essential Oil containing
sesquiterpene ketones,
zingiberene,phellandrene, sabinene,
cineole, and borneol
Yellow pigments known
as diarylheptanoids
including curcuminand
methoxylated curcumins
-
8/13/2019 Inflammation and Disease
23/43
Pharmacodynamics of Turmeric
Curcuminappears to undergo rapid biotransformation
during and after gastrointestinal absorption.
It has been found that 40-85% of an oral dose of curcumin
passes through the gastrointestinal tract unchanged.
Due to its low rate of absorption, it is often formulated
with bromelain and black pepper for increased absorption
as well as enhanced anti-inflammatory effects.
C l h N t l M di i C h i D t b
-
8/13/2019 Inflammation and Disease
24/43
Anti-inflammatory Activity of Turmeric
The anti-inflammatory activity of curcuminwas reported as farback as 1937. In an extension of this work, it was reported that oral doses of
curcuminpossess significant anti-inflammatory action in both acuteand chronic models.
MOA: Dual inhibitor of arachidonic acid metabolism viamodulation of COX-2, prostaglandins, leukotrienes, and othercytokine pathways in the pro-inflammatory signaling pathway.
Dual inhibitors of AA are attracting interest as anti-inflammatoryagents since they prevent potentially damaging effects ofincreased leukotriene production which can result from the useof only COX inhibitors such as aspirin.
Curcuma longa monograph. Natural Medicines Comprehensive Database
-
8/13/2019 Inflammation and Disease
25/43
Evidence Based Medicine
A search for Curcuma longa and inflammation on PubMed
yielded 162 results.
Are Curcuminoids Effective C-Reactive Protein-Lowering
Agents in Clinical Practice? Evidence from a Meta-Analysis.Phytother Res.2013 Aug 7. doi:10.1002/ptr.5045.
This meta-analysis found that ingestion of curcuminoids
significantly decreased CRP levels. The degree of effect was
dependent on bioavailability of curcuminoid compounds used
and the duration of use. The highest yield was amongst subject
ingestion a bio-availability improved curcuminoid for greater
than or equal to 4 weeks.
http://www.ncbi.nlm.nih.gov/pubmed/23922235http://www.ncbi.nlm.nih.gov/pubmed/23922235 -
8/13/2019 Inflammation and Disease
26/43
Evidence Based Medicine
Immune-stimulatory and anti-inflammatory activities ofCurcuma longa extract and its polysaccharide fraction.Pharmacognosy Res.2013 Apr;5(2):71-9. doi: 10.4103/0974-8490.110527.Chandrasekaran CV, Sundarajan K, Edwin JR, Gururaja GM, MundkinajedduD,Agarwal A.
This study demonstrated that an aqueous solution ofcurcuma longa, devoid of curcuminoids, continued topossess anti-inflammatory qualities. This solutionappeared to inhibit IL-12 and PGE2 in vitro.
This study highlights the complexity of herbal therapeuticaction. Even when we identify a therapeutic action, thesynergistic action of the whole plant is often morecomplex.
http://www.ncbi.nlm.nih.gov/pubmed/23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Chandrasekaran%20CV[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Sundarajan%20K[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Edwin%20JR[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Gururaja%20GM[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Mundkinajeddu%20D[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Mundkinajeddu%20D[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Agarwal%20A[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Agarwal%20A[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Mundkinajeddu%20D[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Mundkinajeddu%20D[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Gururaja%20GM[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Edwin%20JR[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Sundarajan%20K[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Chandrasekaran%20CV[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed/23798880 -
8/13/2019 Inflammation and Disease
27/43
Evidence Based Medicine
Curcumin: an orally bioavailable blocker of TNF andother pro-inflammatory biomarkers. Br J Pharmacol.2013Aug;169(8):1672-92. doi: 10.1111/bph.12131.Aggarwal BB, Gupta SC,Sung B.
This meta-analysis examines curcuma longas effects onTNF and discusses its role as an adjunct or substitute topharmacologic TNF blockers.
This analysis references studies from as early as 1937
demonstrating efficacy of turmeric in treating inflammatorydiseases in patients.
There are studies documenting curcuminsefficacy intreating many inflammatory diseases includingrheumatoid arthritis, IBD, many cancers, diabetes, andheart disease.
http://www.ncbi.nlm.nih.gov/pubmed/23425071http://www.ncbi.nlm.nih.gov/pubmed?term=Aggarwal%20BB[Author]&cauthor=true&cauthor_uid=23425071http://www.ncbi.nlm.nih.gov/pubmed?term=Gupta%20SC[Author]&cauthor=true&cauthor_uid=23425071http://www.ncbi.nlm.nih.gov/pubmed?term=Sung%20B[Author]&cauthor=true&cauthor_uid=23425071http://www.ncbi.nlm.nih.gov/pubmed?term=Sung%20B[Author]&cauthor=true&cauthor_uid=23425071http://www.ncbi.nlm.nih.gov/pubmed?term=Gupta%20SC[Author]&cauthor=true&cauthor_uid=23425071http://www.ncbi.nlm.nih.gov/pubmed?term=Aggarwal%20BB[Author]&cauthor=true&cauthor_uid=23425071http://www.ncbi.nlm.nih.gov/pubmed/23425071 -
8/13/2019 Inflammation and Disease
28/43
Evidence Based Medicine
Comparative evaluation of the pain-relieving properties of alecithinized formulation of curcumin (Meriva()), nimesulide, andacetaminophen.J Pain Res.2013;6:201-5. doi: 10.2147/JPR.S42184. Epub 2013 Mar 8.Di Pierro F, Rapacioli G, Di Maio EA,Appendino G, Franceschi F, Togni S.
This pilot study investigated the acute analgesic activity of the curcumin
derivative Meriva. Meriva was compared to nimesulide and acetaminophen and
demonstrated an effect comparable to acetaminophen but less thannimesulide. Meriva was more well tolerated than nimesulide andcomparable to nimesulide. Meriva was utilized at a larger dose than forchronic inflammation (2 g vs 500 mg) in order to achieve this acuteanalgesic effect.
The effect is thought to stem from COX 2 inhibition and desensitization ofreceptor potential A1 (a receptor that also mediates the analgesic effectsof acetaminophen). Additionally, the authors speculate that the long termattenuation of inflammation from the acute supplementation of Merivawould lead to better control of acute pain.
Mills S, Bone K. Principles & Practice of Phytotherapy
http://www.ncbi.nlm.nih.gov/pubmed/23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Di%20Pierro%20F[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Rapacioli%20G[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Di%20Maio%20EA[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Appendino%20G[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Franceschi%20F[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Togni%20S[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Togni%20S[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Franceschi%20F[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Appendino%20G[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Di%20Maio%20EA[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Rapacioli%20G[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Di%20Pierro%20F[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed/23526055 -
8/13/2019 Inflammation and Disease
29/43
Turmeric in Clinical Practice
Preparations: Dried root may be used as a decoction; liquid extract, or capsules.
Dosage:
Powdered rhizome provided at a heaped teaspoon (about 4 grams)mixed with water to a slurry and drank 1-2 times daily. A teaspoon oflecithin can be added to improve absorption.
1:1 liquid extract using 45% ethanol or higher recommended at 5-14ml per day best taken in 4 equal doses throughout the day
Encapsulated common sig is 500 mg QID
Duration of use & safety: May be taken long term within the recommended dosages. No
adverse effects from ingestion of turmeric have been documented atthe recommended dosages.
Mills S, Bone K. Principles & Practice of Phytotherapy
-
8/13/2019 Inflammation and Disease
30/43
Omega-3 Fatty Acids
-
8/13/2019 Inflammation and Disease
31/43
Eicosanoids & Inflammation
Eicosanoids are signaling molecules made byoxygenation of 20-carbon PUFAs
Metabolism product of COX and LOX enzymes
Modulate:
Cell growth and differentiation Intensity and duration of inflammatory response
Immunity
Platelet Aggregation
Angiogenesis
Include: Prostaglandins (PG)
Thromboxanes (TX)
Leukotrienes (LT)
-
8/13/2019 Inflammation and Disease
32/43
EPA and DHA
>15,000 studies
published in past 40
years on health
benefits of EPA & DHA
EPA and DHA are
natural COX-2
inhibitors
-
8/13/2019 Inflammation and Disease
33/43
Conversion Pathway of Omega-3 FA
Alpha-Linolenic Acid (ALA)18:3n-3
Stearidonic Acid
18:4n-3
Eicosatetraenoic Acid20:4n-3
Eicosapentaenoic Acid (EPA)
20:5n-3
Docosapentaenoic Acid (DPA)
22:5n-3
Docosahexaenoic Acid (DHA)
22:6n-3
Anti-Inflammatory
Resolvins & Protectins
Flax, hemp, canola oilsand walnuts
Hemp, modified
vegetable oils, fish
Fish, Fish Oil
Fish, Fish Oil, Algae
6-desaturaseCofactors: B3, B6, Mg, Zn Vit C
Inhibited: alcohol, trans fats,
diabetes, hyperinsulinemia
Dong-Soon IM. Omega-3 fatty acids in anti-inflammation on GPCRs. Progress in Lipid Research. July 2012. 51(3):232-237
-
8/13/2019 Inflammation and Disease
34/43
Resolvins & Protectins
Anti-inflammatory actions that lead to the resolution ofthe inflammatory cycle
Experimental evidence indicates that resolvins and
protectins reduce cellular inflammation by stoppingexcessive neutrophil infiltration and clearing apoptoticPMN leukocytes from sites of inflammation
They are synthesized from either eicosapentaenoic acid(EPA) or docosahexaenoic acid (DHA)
Both series of resolvins (E and D) increase with use oflow dose aspirin or supplementation with EPA/DHA
g g y g p y ( )
-
8/13/2019 Inflammation and Disease
35/43
Evidence Based Medicine
N-3 polyunsatruated fatty acids: relationship to
inflammation in healthy adults and adults exhibiting
features of metabolic syndrome.
Robinson LE, Mazurak VC. Lipids. 2014 Apr;48(4)319-32.
This review article supports the recommendation that a diet
rich in omega-3 fatty acids plays a role in the prevention
and reduction of inflammation.
-
8/13/2019 Inflammation and Disease
36/43
Evidence Based Medicine
Omega-3 fatty acids and inflammatory processes.
Calder PC. Nutrients. 2010 Mar;2(3);355-74
This review article evaluated the mechanisms in which EPA
and DHA modulate inflammation in which they concluded a
variety of mechanisms were involved. Anti-inflammatory
actions of marine n-3 PUFAs were specifically identified to
be useful in inflammatory conditions including RA and
atherosclerosis, however the authors speculate n-3 PUFAswould be useful in nearly all inflammatory conditions due to
the known MOA.
Williams CM, Burdge G. Long-chain n-3 PUFA: Plant v. marine sources. Proc Nutr Soc. 2006 Feb; 65(1):42-50
-
8/13/2019 Inflammation and Disease
37/43
Is Conversion of ALA to LCPUFA
Efficient?
ALA
18:3n-3
EPA
20:5n-3
DPA
22:5n-3
DHA
22:6n-3
0.2-8% Conversion
0.13-6% Conversion
Trace- 0.5% Conversion
An intake of 2 grams
of ALA would yield
approximately 160mg EPA at a
conversion rate of
8% and
approximately 10 mg
DHA at a conversion
rate of 0.5%.
-
8/13/2019 Inflammation and Disease
38/43
Omega-3 as Inflammatory Modulator in
Clinical Practice Ratio
1:2 EPA:DHA
Dose
3 grams EPA+DHA po qd
Reference
Health Canada
Warning: Make sure to have your patients purchase
products that undergo third party testing for purity and
content.
Giugliano D, et al. The effects of diet on inflammation. Journal of Amer Col Card. 2006. 48(4)
-
8/13/2019 Inflammation and Disease
39/43
Anti-Inflammatory Diet
Low consumption of fruit and vegetables, together with physical inactivity, are
now among the top 10 causes of mortality in developed countries.
-
8/13/2019 Inflammation and Disease
40/43
What is an anti-inflammatory diet?
It depends who you ask.
Several different versions, that all have the same basic
guidelines:
Increase omega-3 fatty acids
Increase anti-oxidants
Decrease processed foods
Decrease alcohol and caffeine
Eliminate known allergens
Eliminate sugar
Some guidelines go further and eliminate:
Nightshade vegetables (potato, tomato, eggplant, bell peppers etc.)
Common allergens like soy, peanuts, gluten, dairy, & eggs
Sears B, Ricordi C. Anti-inflammatory nutrition as a pharmacological approach to treat obesity. J Obes. 2011
-
8/13/2019 Inflammation and Disease
41/43
MOA of Diet and Inflammation
Dietary intake of arachidonic acid up-regulates
prostaglandin synthesis.
Increased prostaglandin and inflammation leads to insulin
resistance and lipid oxidation.
This leads to increases in silent inflammation and
obesity.
Greater intake of antioxidant containing foods reduces
inflammatory cytokines and mitigates this process.
-
8/13/2019 Inflammation and Disease
42/43
Inflammation and Disease
Inflammation has been implicated in many chronic
diseases.
There are many ways to decrease inflammation through
diet and lifestyle.
Herbs and fish oil are a helpful adjunct to these
interventions.
By addressing inf lammation as a preventive measure,
we can work towards in creasing qual i ty of l i fe and
decreasing morbid i ty and mortali ty in ou r pat ients.
-
8/13/2019 Inflammation and Disease
43/43
Contact Information
503-552-1874
mailto:[email protected]:[email protected]